Biocon in pact with Mylan for biologic drugs

Reuters
Posted: Monday, Jun 29, 2009 at 1149 hrs IST
Updated: Monday, Jun 29, 2009 at 1149 hrs IST

Font Size

Feedback

Discuss

GSK Pharma Q3 profit rises 7%Dr Reddy's Q2 net up 3 fold at Rs 240 cr Piramal Healthcare Q2 net up 45 pct Ranbaxy hails US court ruling on Valcyte patent

Mumbai : Biotechnology firm Biocon Ltd said on Monday it has signed a definitive agreement with Mylan Inc to develop, manufacture and supply generic biologic drugs globally.

As part of the agreement, both companies will share development, capital and other costs to bring the products to market, it said in a statement.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.